2011 - Fellow of the American Association for the Advancement of Science (AAAS)
2009 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
Sickle cell anemia, Internal medicine, Pediatrics, Stroke and Anemia are his primary areas of study. His Sickle cell anemia research integrates issues from Cerebral infarction, Hemolytic anemia, Hemoglobinopathy, El Niño and Asthma. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology, Surgery and Cardiology.
His Pediatrics research incorporates elements of Physical therapy, Affect, Cohort study and Prospective cohort study. Michael R. DeBaun has researched Stroke in several fields, including Epidemiology and Intensive care medicine. Michael R. DeBaun combines subjects such as Cross-sectional study, Randomized controlled trial, Disease, Blood transfusion and Cohort with his study of Anemia.
Michael R. DeBaun spends much of his time researching Disease, Pediatrics, Sickle cell anemia, Internal medicine and Anemia. His Disease study integrates concerns from other disciplines, such as Cell, Clinical trial, Cognition, Family medicine and Intensive care medicine. The various areas that Michael R. DeBaun examines in his Pediatrics study include Incidence, Cohort study, Retrospective cohort study, Asthma and Prospective cohort study.
His work in Sickle cell anemia addresses issues such as Stroke, which are connected to fields such as Blood transfusion and Randomized controlled trial. His study looks at the intersection of Internal medicine and topics like Surgery with Beckwith–Wiedemann syndrome. His study in Beckwith–Wiedemann syndrome is interdisciplinary in nature, drawing from both Wilms' tumor and Genomic imprinting.
His scientific interests lie mostly in Disease, Sickle cell anemia, Internal medicine, Pediatrics and Anemia. His Disease study combines topics from a wide range of disciplines, such as Cell, Clinical trial, Family medicine, Intensive care medicine and Obstetrics. His Sickle cell anemia research is multidisciplinary, relying on both Priapism, Genetic disorder, Cognition, Transcranial Doppler and Stroke prevention.
His Internal medicine research integrates issues from Gastroenterology and Cardiology. The Pediatrics study combines topics in areas such as Stroke, Primary prevention, Body mass index and Health services research. His Anemia research is multidisciplinary, relying on both Heterozygote advantage, Ultrasonography, Cohort and MEDLINE.
His primary areas of study are Disease, Pediatrics, Anemia, Sickle cell anemia and Cell. Michael R. DeBaun has included themes like Clinical trial, MEDLINE, Quality of life, Intensive care medicine and Cohort in his Disease study. Michael R. DeBaun has researched Pediatrics in several fields, including Stroke, Mentorship, Debriefing and Health policy.
His Anemia research incorporates elements of Homologous chromosome, Blood transfusion and Bioinformatics. His Sickle cell anemia study is associated with Internal medicine. His Cell research includes elements of Cerebral hemodynamics, Fixed dose, Primary prevention, Pathology and Bone marrow transplantation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association of In Vitro Fertilization with Beckwith-Wiedemann Syndrome and Epigenetic Alterations of LIT1 and H19
Michael R. DeBaun;Emily L. Niemitz;Andrew P. Feinberg.
American Journal of Human Genetics (2003)
Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry
Michael R. DeBaun;Margaret A. Tucker.
The Journal of Pediatrics (1998)
Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith–Wiedemann syndrome and is independent of insulin-like growth factor II imprinting
Maxwell P. Lee;Michael R. DeBaun;Kohzoh Mitsuya;Heidi L. Galonek.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary
Michael S. Watson;Marie Y. Mann;Michele A. Lloyd-Puryear;Piero Rinaldo.
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia
Michael R DeBaun;Mae Gordon;Robert C McKinstry;Michael J Noetzel.
The New England Journal of Medicine (2014)
Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease
Charles H. Pegelow;Eric A. Macklin;Franklin G. Moser;Winfred C. Wang.
Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects.
Michael R. DeBaun;Michael R. DeBaun;Emily L. Niemitz;D. Elizabeth McNeil;Sheri A. Brandenburg.
American Journal of Human Genetics (2002)
Silent Cerebral Infarcts in Sickle Cell Anemia: A Risk Factor Analysis
Thomas R. Kinney;Lynn A. Sleeper;Winfred C. Wang;Robert A. Zimmerman.
Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease.
Scott T. Miller;Eric A. Macklin;Charles H. Pegelow;Thomas R. Kinney.
The Journal of Pediatrics (2001)
Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease
J. Schatz;R. T. Brown;J. M. Pascual;L. Hsu.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: